BRPI0518655A2 - composiÇço oral para o tratamento, inibiÇço ou reduÇço de uma condiÇço inflamatària oral, mÉtodo de pelo menos um dentre tratar e inibir uma condiÇço inflamatària oral, composiÇço de cuidado oral, e, mÉtodo de pelo menos um dentre tratar e inibir uma condiÇço inflamatària oral e prover atividade antioxidante em uma cavidade oral - Google Patents

composiÇço oral para o tratamento, inibiÇço ou reduÇço de uma condiÇço inflamatària oral, mÉtodo de pelo menos um dentre tratar e inibir uma condiÇço inflamatària oral, composiÇço de cuidado oral, e, mÉtodo de pelo menos um dentre tratar e inibir uma condiÇço inflamatària oral e prover atividade antioxidante em uma cavidade oral

Info

Publication number
BRPI0518655A2
BRPI0518655A2 BRPI0518655-2A BRPI0518655A BRPI0518655A2 BR PI0518655 A2 BRPI0518655 A2 BR PI0518655A2 BR PI0518655 A BRPI0518655 A BR PI0518655A BR PI0518655 A2 BRPI0518655 A2 BR PI0518655A2
Authority
BR
Brazil
Prior art keywords
oral
inhibiting
treating
inflammatory condition
composition
Prior art date
Application number
BRPI0518655-2A
Other languages
English (en)
Inventor
Cortney L Worrell
Harsh M Trivedi
Kimberlee Panaligan
Tao Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BRPI0518655A2 publication Critical patent/BRPI0518655A2/pt
Publication of BRPI0518655B1 publication Critical patent/BRPI0518655B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIÇçO ORAL PARA O TRATAMENTO, INIBIÇçO OU REDUÇçO DE UMA CONDIÇçO INFLAMATàRIA ORAL, MÉTODO DE PELO MENOS UM DENTRE TRATAR E JMBIR UMA CONDIÇçO INFLAMATàRIA ORAL, COMPOSIÇçO DE CUIDADO ORAL, E, MÉTODO DE PELO MENOS UM DENTRE TRATAR E IMBIR UMA CONDIÇçO INFLAMATàRIA ORAL E PROVER ATIVIDADE ANTIOXIDANTE EM UMA CAVIDADE ORAL. Uma composição oral para pelo menos um dentre tratar e inibir uma condição inflamatória oral compreendendo: um extrato de Carne/lia incluindo pelo menos cerca de 30% de gaiato de epigalocatequina, pelo menos cerca de 50% de catequinas no total, e pelo menos cerca de 60% de polifenóis no total, e um agente anti-bacteriano não catiônico substancialmente insolúvel em água.
BRPI0518655-2A 2004-12-23 2005-12-21 composição oral para o tratamento, inibição ou redução de uma condição inflamatória oral BRPI0518655B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US63907904P 2004-12-23 2004-12-23
US63908004P 2004-12-23 2004-12-23
US60/639,080 2004-12-23
US60/639,079 2004-12-23
US11/256,860 2005-10-24
US11/256,860 US8895084B2 (en) 2004-12-23 2005-10-24 Oral care composition containing extract of unoxidized Camellia
PCT/US2005/046242 WO2006071655A1 (en) 2004-12-23 2005-12-21 Oral care composition containing extract of unoxidized camellia

Publications (2)

Publication Number Publication Date
BRPI0518655A2 true BRPI0518655A2 (pt) 2008-12-02
BRPI0518655B1 BRPI0518655B1 (pt) 2015-09-08

Family

ID=36390249

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518655-2A BRPI0518655B1 (pt) 2004-12-23 2005-12-21 composição oral para o tratamento, inibição ou redução de uma condição inflamatória oral

Country Status (14)

Country Link
US (1) US8895084B2 (pt)
EP (1) EP1830800B1 (pt)
CN (1) CN102626378A (pt)
AR (1) AR053001A1 (pt)
AT (1) ATE507815T1 (pt)
AU (1) AU2005322193B2 (pt)
BR (1) BRPI0518655B1 (pt)
CA (1) CA2592122C (pt)
DE (1) DE602005027899D1 (pt)
DK (1) DK1830800T3 (pt)
MX (1) MX2007007707A (pt)
PL (1) PL1830800T3 (pt)
TW (1) TWI396557B (pt)
WO (1) WO2006071655A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP1503778B1 (en) 2002-04-30 2009-08-05 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
BRPI0409179A (pt) 2003-04-04 2006-05-02 Unigen Pharmaceuticals Inc formulação de inibidores duplos de ciclooxigenase (cox) e lipoxigenase (lox) para cuidados com a pele de mamìferos
US20070140990A1 (en) 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
EP2192910A1 (en) 2007-10-01 2010-06-09 Colgate-Palmolive Company Oral compositions containing botanical extracts
MX337177B (es) * 2008-02-08 2016-02-16 Colgate Palmolive Co Sales de arginina y sus usos para el tratamiento de enfermedades en la cavidad oral.
AU2009240294B2 (en) * 2008-04-24 2014-04-10 Indena S.P.A. Compositions for the treatment and prevention of infections of the oral cavity
EP2348838B1 (en) * 2008-10-20 2013-05-08 Unilever NV An antimicrobial composition
US8399220B2 (en) * 2009-04-16 2013-03-19 Forsyth Dental Infirmary For Children Antibacterial compositions
AU2010297406B2 (en) 2009-09-24 2013-10-17 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
MX2012005421A (es) 2009-12-04 2012-06-14 Colgate Palmolive Co Composiciones orales que contienen extractos de zizyphus joazeiro y metodos relacionados.
MY152711A (en) 2009-12-04 2014-11-28 Colgate Palmolive Co Oral compositions containing a combination of natural extracts and related methods
CA2780172A1 (en) 2009-12-04 2011-06-09 Colgate-Palmolive Company Oral compositions containing extracts of myristica fragrans and related methods
CA2779906A1 (en) 2009-12-04 2011-06-09 Colgate-Palmolive Company Oral compositions containing extracts of garcinia mangostana l. and related methods
EP2712657A1 (en) 2009-12-04 2014-04-02 Colgate-Palmolive Company Oral compositions containing extracts of zingiber officinale and related methods
US8715625B1 (en) 2010-05-10 2014-05-06 The Clorox Company Natural oral care compositions
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition
CA2825139C (en) 2011-01-31 2017-04-04 Colgate-Palmolive Company Oral care compositions
AU2012305675B2 (en) * 2011-09-09 2017-10-05 Kemin Industries, Inc. Antioxidant formulations
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition
EP2782550A2 (en) * 2011-11-25 2014-10-01 Unilever N.V. An oral care composition comprising polyphenol
WO2013092117A2 (en) * 2011-12-20 2013-06-27 Unilever N.V. An oral care composition
WO2014033314A1 (en) 2012-09-03 2014-03-06 Uab Bioseka Antisense oligonucleotide targeting bacterial glucosyltransferases
DE102014221669A1 (de) * 2014-10-24 2016-04-28 Henkel Ag & Co. Kgaa Verwendung eines phenolhaltigen Extrakts aus Camellia sinensis in Mund- und Zahnreinigungsmitteln zur Verbesserung des optischen Erscheinungsbildes des Zahnfleischs
US20200330408A1 (en) * 2017-12-22 2020-10-22 Conopco, Inc., D/B/A Unilever An antimicrobial composition
CN108514112A (zh) * 2018-03-12 2018-09-11 广东康侨药业有限公司 一种改善口腔健康的营养组合物及其用途
US12311044B2 (en) 2018-12-18 2025-05-27 Conopco, Inc. Antimicrobial composition
US12447119B2 (en) 2019-03-18 2025-10-21 Sunstar Americas, Inc. Oral care composition

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3122565A (en) 1960-10-22 1964-02-25 Eisai Co Ltd Purification process of tocopherol containing materials
US4550183A (en) 1984-08-02 1985-10-29 Henkel Corporation Purification of tocopherols
JPH0635376B2 (ja) 1985-02-27 1994-05-11 サンスタ−株式会社 口腔用組成物
US5180578A (en) 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
US5080887A (en) 1987-01-30 1992-01-14 Colgate-Palmolive Company Antibacterial antiplaque, anticalculus oral composition
US5344641A (en) 1987-01-30 1994-09-06 Colgate-Palmolive Co. Antibacterial antiplaque oral composition
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
SE512333C2 (sv) 1989-08-25 2000-02-28 Colgate Palmolive Co Antibakteriell oral komposition med plack- och tandstensbegränsande verkan
SE9402453D0 (sv) 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
US5681548A (en) 1994-07-15 1997-10-28 Colgate Palmolive Company Oral formulations
US5683678A (en) 1995-03-09 1997-11-04 The Procter & Gamble Company Oral compositions
IT1275905B1 (it) 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
US5723500A (en) 1995-09-22 1998-03-03 Colgate-Palmolive Company Antiplaque oral composition and method
US5912274A (en) 1995-09-22 1999-06-15 Colgate-Palmolive Company Antiplaque oral composition and method
US20030206874A1 (en) 1996-11-21 2003-11-06 The Proctor & Gamble Company Promoting whole body health
US5910308A (en) 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
FR2763843B1 (fr) 1997-05-30 1999-08-20 Marie Pratt Composition ayant notamment une action anti-vieillissement de la peau
JP3763075B2 (ja) 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
US6149894A (en) * 1999-05-14 2000-11-21 Colgate Palmolive Company Method for the manufacture of toothpaste
CN1367663A (zh) 1999-09-08 2002-09-04 Amt技术公司 眼睛生物计
US6290933B1 (en) 2000-05-09 2001-09-18 Colgate-Palmolive Company High cleaning dentifrice
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells
US6403059B1 (en) 2000-08-18 2002-06-11 J. M. Huber Corporation Methods of making dentifrice compositions and products thereof
US6685921B2 (en) 2000-10-25 2004-02-03 The Procter & Gamble Company Dental care compositions
RU2203032C1 (ru) 2002-04-22 2003-04-27 Открытое акционерное общество "Косметическое объединение "Свобода" Средство для чистки зубов
EP1504754A4 (en) * 2002-05-10 2006-03-15 Suntory Ltd GALLOCATECHIN COMPOSITION CONTAINING GALLATE
US20030235630A1 (en) 2002-06-21 2003-12-25 Nussen Kenneth H. Dental hygiene products and methods of making dental hygiene products
US20030235606A1 (en) 2002-06-21 2003-12-25 Nussen Kenneth H. Oral hygiene products and methods of making oral hygiene products
US20050025719A1 (en) 2002-06-21 2005-02-03 Nussen Kenneth H. Method and apparatus for oral hygiene products with green tea extract
GB0303677D0 (en) 2003-02-18 2003-03-19 Quest Int Flavoured products
RU2241437C1 (ru) 2003-04-28 2004-12-10 Открытое акционерное общество "Косметическое объединение "Свобода" Зубная паста "пародонтол" с экстрактом зеленого чая, фтором, витаминами а и е
US20050079140A1 (en) 2003-10-08 2005-04-14 Nussen Kenneth H. Toothpaste formulation with green tea extract and fluoride

Also Published As

Publication number Publication date
AU2005322193A1 (en) 2006-07-06
AU2005322193B2 (en) 2011-10-20
BRPI0518655B1 (pt) 2015-09-08
ATE507815T1 (de) 2011-05-15
WO2006071655A1 (en) 2006-07-06
TWI396557B (zh) 2013-05-21
DE602005027899D1 (de) 2011-06-16
AR053001A1 (es) 2007-04-18
EP1830800A1 (en) 2007-09-12
TW200637608A (en) 2006-11-01
EP1830800B1 (en) 2011-05-04
DK1830800T3 (da) 2011-08-15
CA2592122C (en) 2014-07-15
CA2592122A1 (en) 2006-07-06
US20060141073A1 (en) 2006-06-29
US8895084B2 (en) 2014-11-25
PL1830800T3 (pl) 2011-10-31
CN102626378A (zh) 2012-08-08
HK1107276A1 (en) 2008-04-03
MX2007007707A (es) 2007-08-14

Similar Documents

Publication Publication Date Title
BRPI0518655A2 (pt) composiÇço oral para o tratamento, inibiÇço ou reduÇço de uma condiÇço inflamatària oral, mÉtodo de pelo menos um dentre tratar e inibir uma condiÇço inflamatària oral, composiÇço de cuidado oral, e, mÉtodo de pelo menos um dentre tratar e inibir uma condiÇço inflamatària oral e prover atividade antioxidante em uma cavidade oral
YU75003A (sh) Nutriciona farmaceutska formulacija koja uključuje polifenole i upotreba u tretmanu kancera
MXPA03000041A (es) Composiciones orales que comprenden agentes microbianos.
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
BRPI0518776A2 (pt) composiÇço e mÉtodo para o cuidado oral, e, mÉtodos para inibir a inflamaÇço em um tecido oral de um paciente, e para promover a saéde oral em um paciente
WO2005046618A3 (en) Methods of treating eczema
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
DE60329098D1 (de) Verwendung von mastix und dessen ätherischen ölen zur verhinderung oder bekämpfung von mikrobieller infektionen
ATE446088T1 (de) Epigallocatechin-gallate zur hemmung von angiogenese
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
ATE500747T1 (de) Zusammensetzung zur erhöhung der leistungsfähigkeit des körpers
BRPI0416731A (pt) métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor
BR0112280A (pt) Nova utilização para deferiprona
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
PT1631275E (pt) Tratamento e prevenção da cicatrização excessiva com 4-hidroxi-tamoxifeno
BRPI0514390A (pt) enanciÈmero de um composto ou um sal farmacêuticamente aceitável ou um éster hidrolisável in vivo do mesmo, uso do mesmo, métodos para o tratamento de cáncer, para produzir um efeito inibidor de eg5 em um animal de sangue quente e para tratar doenças, e, composição farmacêutica
BRPI0913665B8 (pt) composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
BR0115880A (pt) Emprego de compostos ciclohexanona de 6-dimetilaminometila-1-fenil para o tratamento da incontinência urinária
MX2021010491A (es) Tratamiento de fibromas con vitamina d y un agente tal como galato de epigalocatequina (egcg).
RU2007127861A (ru) Композиция для ухода за полостью рта, содержащая экстракт неокисленной camellia

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2005, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.